The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Community Fast Track, 2005Use of NR2D-selective NMDA Receptor Modulators in the Treatment of PD
The frontline pharmacological treatment for Parkinson's disease is associated with serious side effects, creating a need for new therapeutic strategies. Recent evidence suggests that selective...
-
Community Fast Track, 2005The role of serotonin neurons in the induction and maintenance of dyskinesias in grafted and L-DOPA-primed animals
Background: Levodopa, the most commonly used medication for patients with Parkinson's disease, is a beneficial therapy, but as the disease progresses it can be the cause of debilitating involuntary...
-
LEAPS, 2005New Small Molecule Inhibiting Agents of Alpha-Synuclein & Lewy Body Formation as Disease-Modifying Treatments for Parkinson's Disease
Parkinson's Disease is pathologically characterized by the presence and accumulation of a protein known as alpha-synuclein. Mutations in alpha-synuclein have been directly linked to PD, and alpha...
-
LEAPS, 2005Development and Optimization of a Regulatable Gene Switch for Gene Therapies of Parkinson’s Disease
Gene therapy holds tremendous potential for the treatment of Parkinson's disease. By using a virus or other DNA delivery system to permanently insert a new gene into critical regions of a Parkinson...
-
Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006The ReStore Study
Apathy is a syndrome characterized by a primary lack of motivation and is manifested as a lack of effort and productivity, dependence on others for structuring daily activities, loss of interest in...
-
Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006Development of a Model of Postural Disturbance by Lesioning Non-cholinergic Neurons
Mounting evidence suggests that a small structure at the bottom of the brain called pedunculopontine nucleus is involved in the development of gait failure and postural instability in PD. We propose...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.